Dr. Scott Struthers, founder and CEO of Crinetics Pharmaceuticals discusses drug development updates for pituitary patients with Pituitary World News

During these unprecedented times, Crinetics continues to work on new drugs and therapies for pituitary patients. Dr. Scott Struthers discusses the latest on Crinetics Pharmaceuticals’ new drugs currently under development with Pituitary World News‘ co-founder, J D Faccinetti.

We wondered how this critically important work for pituitary patients was affected by the pandemic. Dr. Struthers gives us an “insider’s view” of their work and an update on the progress in the development of these new medications for acromegaly, neuroendocrine tumors, congenital hyperinsulinism, Cushing’s disease, congenital adrenal hyperplasia, and more.

Listen to the podcast here:

Click here to learn more about getting involved. Visit the Pituitary World News podcasts series on new drug development, “The Journey to a New Drug” for more in-depth information on this topic.